Androgenic Alopecia TH07 Clinical Trial

Inclusion Criteria

• •Males, 18 to 49 years of age on the date of enrollment.
• •Presenting with androgenic alopecia measured as III vertex to V on Hamilton Norwood Scale.
• •Body Mass Index (BMI) in the range of 19 to 35 kg/m2.
• •Not administered any systemic or topical treatment for AGA during the last 90 days.
• •Willing to comply with the following restrictions for the duration of trial participation:
• •1. Any systemic or topical treatment of any system of medicine (other than trial treatment) for AGA.
• •2. Hair dyes, hair texturizers, relaxers etc.
• •3. Any new vitamins or nutritional supplements that are currently not being administered.
• •4. Tattooing in the trial target area.
• •5. Blood donations.
• •6. OTC hair restorers.
• •7. Do not expose your pregnant partner to your hands/skin where the drug might be present.
• •8. Participation in any other drug or device trials during the course of this trial.
• •Note: However, the following shall be permissible:
• •9. Non-medicated \& anti-dandruff shampoos, scalp/hair applications including styling gels, sprays, mousse (styling gels, sprays, mousse etc. not to be used on the days of trial visits to the clinic.
• •10. Current regimen (if any) of vitamins and nutritional supplements.
• •Willing and able to provide written informed consent for participation in the trial and to comply with all trial requirements.
• •Availability of and usage familiarity with a personal mobile phone (Android or iOS) with internet connectivity and a personal email address.